» Articles » PMID: 28222188

The Thermodynamics of Pr55Gag-RNA Interaction Regulate the Assembly of HIV

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2017 Feb 22
PMID 28222188
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The interactions that occur during HIV Pr55Gag oligomerization and genomic RNA packaging are essential elements that facilitate HIV assembly. However, mechanistic details of these interactions are not clearly defined. Here, we overcome previous limitations in producing large quantities of full-length recombinant Pr55Gag that is required for isothermal titration calorimetry (ITC) studies, and we have revealed the thermodynamic properties of HIV assembly for the first time. Thermodynamic analysis showed that the binding between RNA and HIV Pr55Gag is an energetically favourable reaction (ΔG<0) that is further enhanced by the oligomerization of Pr55Gag. The change in enthalpy (ΔH) widens sequentially from: (1) Pr55Gag-Psi RNA binding during HIV genome selection; to (2) Pr55Gag-Guanosine Uridine (GU)-containing RNA binding in cytoplasm/plasma membrane; and then to (3) Pr55Gag-Adenosine(A)-containing RNA binding in immature HIV. These data imply the stepwise increments of heat being released during HIV biogenesis may help to facilitate the process of viral assembly. By mimicking the interactions between A-containing RNA and oligomeric Pr55Gag in immature HIV, it was noted that a p6 domain truncated Pr50Gag Δp6 is less efficient than full-length Pr55Gag in this thermodynamic process. These data suggest a potential unknown role of p6 in Pr55Gag-Pr55Gag oligomerization and/or Pr55Gag-RNA interaction during HIV assembly. Our data provide direct evidence on how nucleic acid sequences and the oligomeric state of Pr55Gag regulate HIV assembly.

Citing Articles

Structural and computational studies of HIV-1 RNA.

Levintov L, Vashisth H RNA Biol. 2023; 21(1):1-32.

PMID: 38100535 PMC: 10730233. DOI: 10.1080/15476286.2023.2289709.


Expression, purification, and functional characterization of soluble recombinant full-length simian immunodeficiency virus (SIV) Pr55.

Pillai V, Ali L, Prabhu S, Krishnan A, Tariq S, Mustafa F Heliyon. 2023; 9(1):e12892.

PMID: 36685375 PMC: 9853374. DOI: 10.1016/j.heliyon.2023.e12892.


Quantifying membrane binding and diffusion with fluorescence correlation spectroscopy diffusion laws.

Mouttou A, Bremaud E, Noero J, Dibsy R, Arone C, Mak J Biophys J. 2023; 122(11):2216-2229.

PMID: 36632034 PMC: 10257123. DOI: 10.1016/j.bpj.2023.01.006.


Distinct Gag interaction properties of HIV-1 RNA 5' leader conformers reveal a mechanism for dimeric genome selection.

Yang X, Liu Y, Cui W, Liu M, Wang W RNA. 2022; 29(2):217-227.

PMID: 36384962 PMC: 9891258. DOI: 10.1261/rna.079347.122.


Calcium Contributes to Polarized Targeting of HIV Assembly Machinery by Regulating Complex Stability.

Kishor C, Spillings B, Luhur J, Lutomski C, Lin C, McKinstry W JACS Au. 2022; 2(2):522-530.

PMID: 35253001 PMC: 8889552. DOI: 10.1021/jacsau.1c00563.


References
1.
McKinstry W, Hijnen M, Tanwar H, Sparrow L, Nagarajan S, Pham S . Expression and purification of soluble recombinant full length HIV-1 Pr55(Gag) protein in Escherichia coli. Protein Expr Purif. 2014; 100:10-8. DOI: 10.1016/j.pep.2014.04.013. View

2.
Campbell S, Rein A . In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J Virol. 1999; 73(3):2270-9. PMC: 104472. DOI: 10.1128/JVI.73.3.2270-2279.1999. View

3.
El Meshri S, Dujardin D, Godet J, Richert L, Boudier C, Darlix J . Role of the nucleocapsid domain in HIV-1 Gag oligomerization and trafficking to the plasma membrane: a fluorescence lifetime imaging microscopy investigation. J Mol Biol. 2015; 427(6 Pt B):1480-1494. DOI: 10.1016/j.jmb.2015.01.015. View

4.
van der Kuyl A, Berkhout B . The biased nucleotide composition of the HIV genome: a constant factor in a highly variable virus. Retrovirology. 2012; 9:92. PMC: 3511177. DOI: 10.1186/1742-4690-9-92. View

5.
Velkov T . Thermodynamics of lipophilic drug binding to intestinal fatty acid binding protein and permeation across membranes. Mol Pharm. 2009; 6(2):557-70. DOI: 10.1021/mp800227w. View